Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 138-143, July 2006

Intensity-Modulated Radiation Therapy for Gynecologic Cancers: Pitfalls, Hazards, and Cautions To Be Considered

  • Marcus E. Randall, MD, FACR

      Affiliations

    • Leo W. Jenkins Cancer Center and Brody School of Medicine, East Carolina University, Greenville, NC.
    • Corresponding Author InformationAddress reprint requests to Marcus E. Randall, MD, FACR, Department of Radiation Oncology, Leo W. Jenkins Cancer Center, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27834.
  • ,
  • Geoffrey S. Ibbott, PhD, FACR, FAAPM

      Affiliations

    • Radiological Physics Center, UT M. D. Anderson Cancer Center, Houston, TX

Intensity Modulated Radiation Therapy (IMRT) is considered a major advance in radiaton therapy (RT) capability. Therefore, it has been rapidly accepted and implemented in the treatment of multiple cancers in which RT plays a major role. Early reports of IMRT in gynecologic cancers have been largely favorable, particularly in terms of decreased acute morbidity. However, IMRT has not been prospectively shown to be superior to conventional 3-dimensional RT techniques when judged against criteria established in advance. Furthermore, there are many reasons to consider the possibility that outcomes might be compromised by IMRT techniques used to treat gynecologic cancers. This article reviews the potential pitfalls and hazards of IMRT techniques on patient safety and treatment efficacy. In addition, the article describes multiple technical issues with IMRT implementation, arguing for caution in IMRT use.

Keywords:  Intensity Modulated Radiation Therapy (IMRT) , radiation-induced malignancies , organ motion , target motion , radiobiology of IMRT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(06)00003-8

doi:10.1016/j.semradonc.2006.02.002

Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 138-143, July 2006